San Diego-based Cue Health, which develops health information software, has raise $235M in a financing round, the company said on Thursday. The funding came from Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, plus existing investors Johnson & Johnson Innovation -- JJDC, Inc. (JJDC), Decheng Capital, CAVU Ventures, ACME Capital, and others. Cue Health's co-foudner and CEO is Ayub Khattak. Cue's flagship product is the Cue Health monitoring System. The company also develops the over-the-counter Cue COVID-19 Test Kit, an FDA authorized molecular-based diagnostic test.